Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 9 August 2011 on appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance)

Rozhodnutie č. 810/2011

Text language

Important dates

Declared: 9. augusta 2011
Approved: 9. augusta 2011
Effective from: 1. septembra 2011
Effective until: 1. septembra 2014

Documents and links

COMMISSION DECISION

of 9 August 2011

on appointing members of the Committee for Orphan Medicinal Products

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,

Having regard to the recommendation of the European Medicines Agency of 25 May 2011,

Whereas:

(1)

The term of office of two members of the Committee for Orphan Medicinal Products which were appointed by the Commission on the recommendation from the European Medicines Agency expired in July 2011.

(2)

The European Medicines Agency has recommended the reappointment of these persons.

(3)

The members of the Committee shall be appointed for a period of three years starting on 1 September 2011,

HAS DECIDED AS FOLLOWS:

Sole Article

On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for Orphan Medicinal Products for a term of three years from 1 September 2011:

 

Prof. János BORVENDÉG

 

Prof. Bruno SEPODES

Done at Brussels, 9 August 2011.

For the Commission

John DALLI

Member of the Commission

Poznámky